Merited Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Merited Wealth’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-35	Closed	-$20.3K	–	263
2025 Q4	$20.3K	Buy	+35	New	+$19.8K	0.02%	167

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Merited Wealth's TMO Position: Q1 2026 in Review

Merited Wealth sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 35 shares — an estimated $20.3K sold.

Merited Wealth first reported a position in TMO in Q4 2025 and held it in 1 quarter. The position peaked at $20.3K in Q4 2025. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Merited Wealth reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Merited Wealth sold 35 Thermo Fisher Scientific shares in Q1 2026, an estimated $20.3K.
Merited Wealth first reported a position in Thermo Fisher Scientific in Q4 2025 and held it in 1 quarter.
Merited Wealth's Thermo Fisher Scientific position peaked at $20.3K in Q4 2025.
2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Merited Wealth's 13F filing for Q1 2026, filed 24 Apr 2026.